Glenmark Life Sciences
₹1,086
45
+₹13.55+1.26% Friday 09:59
Statistics
Day High
1,095
Day Low
1,056.8
52W High
1,335.1
52W Low
676.5
Volume
130,897
Avg. Volume
112,732
Mkt Cap
0
P/E Ratio
31.45
Dividend Yield
0.46%
Dividend
5
Upcoming
Dividends
0.46%Dividend Yield
Sep 25
₹5
Oct 23
₹22.5
Mar 23
₹21
Sep 22
₹10.5
Dec 21
₹10.5
10Y Growth
N/A
5Y Growth
-13.79%
3Y Growth
-51.38%
1Y Growth
N/A
Earnings
17OctExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
0Net Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GLS.NSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Alivus Life Sciences Limited develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas, including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives. The company also provides contract development and manufacturing services to a range of multinational corporations and specialty companies. It exports its products. The company was formerly known as Glenmark Life Sciences Limited and changed its name to Alivus Life Sciences Limited in December 2024. The company was founded in 2001 and is based in Mumbai, India. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.
Show more...
CEO
Dr. Yasir Yusufali Rawjee Ph.D.
Employees
2014
Country
IN
ISIN
INE03Q201024
Listings
0 Comments
Share your thoughts
FAQ
What is Glenmark Life Sciences stock price today?▼
The current price of GLS.NSE is ₹1,086 INR — it has increased by +1.26% in the past 24 hours. Watch Glenmark Life Sciences stock price performance more closely on the chart.
What is Glenmark Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Glenmark Life Sciences stocks are traded under the ticker GLS.NSE.
What is Glenmark Life Sciences revenue for the last year?▼
Glenmark Life Sciences revenue for the last year amounts to 0 INR.
What is Glenmark Life Sciences net income for the last year?▼
GLS.NSE net income for the last year is 0 INR.
Does Glenmark Life Sciences pay dividends?▼
Yes, GLS.NSE dividends are paid annual. The last dividend per share was 5 INR. As of today, Dividend Yield (FWD)% is 0.46%.
How many employees does Glenmark Life Sciences have?▼
As of April 04, 2026, the company has 2,014 employees.
In which sector is Glenmark Life Sciences located?▼
Glenmark Life Sciences operates in the Health Care sector.
When did Glenmark Life Sciences complete a stock split?▼
Glenmark Life Sciences has not had any recent stock splits.
Where is Glenmark Life Sciences headquartered?▼
Glenmark Life Sciences is headquartered in Mumbai, IN.